Overview
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2023-10-20. Active
Debt
3 active proceedings recorded in KRZ. Active proceeding
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Jan 8, 2025 | Arrangement proceedings | In progress | |
| Dec 6, 2024 | Petition to open arrangement proceedings | Closed | |
| Oct 8, 2024 | Petition to declare entrepreneur bankruptcy | Closed |
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $338.4K$338,364 |
Buildings and premises | $3.0M$2,961,813 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 10, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $7,371$7,371 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Sep 10, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $581$581 | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the sole member of the management board is authorised to represent the company and make declarations of will on its behalf. In the case of a two-person management board, two members of the management board acting jointly or the Vice-President of the Management Board acting jointly with a commercial proxy are authorised to represent the company and make declarations of will on its behalf.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Grzegorz Franciszek Nowakowski (71) | 999 | $26,985.41 | 99.9% |
Others | 1 | $27.01 | 0.1% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Gemi Conceptsp. z o.o. | 1,350.62 USD | 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| BiotonS.A. | $72,911,351.08 | bioton.com | ||
| Celon PharmaS.A. | $52,550,739.16 | celonpharma.com | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| VipharmS.A. | $30,660,173.61 | vipharm.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-03-07 | Name change (Gemipharma → Gemipharma Spółka Z Ograniczoną Odpowiedzialnością W Restrukturyzacji) | |
| 2023-09-29 | Entered in the register |
FAQ
Last updated: 2026-04-26